Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis.

Smith BN, Topp SD, Fallini C, Shibata H, Chen HJ, Troakes C, King A, Ticozzi N, Kenna KP, Soragia-Gkazi A, Miller JW, Sato A, Dias DM, Jeon M, Vance C, Wong CH, de Majo M, Kattuah W, Mitchell JC, Scotter EL, Parkin NW, Sapp PC, Nolan M, Nestor PJ, Simpson M, Weale M, Lek M, Baas F, Vianney de Jong JM, Ten Asbroek ALMA, Redondo AG, Esteban-Pérez J, Tiloca C, Verde F, Duga S, Leigh N, Pall H, Morrison KE, Al-Chalabi A, Shaw PJ, Kirby J, Turner MR, Talbot K, Hardiman O, Glass JD, De Belleroche J, Maki M, Moss SE, Miller C, Gellera C, Ratti A, Al-Sarraj S, Brown RH Jr, Silani V, Landers JE, Shaw CE.

Sci Transl Med. 2017 May 3;9(388). pii: eaad9157. doi: 10.1126/scitranslmed.aad9157.

2.

Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways.

Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS, Couthouis J, Lu YF, Wang Q, Krueger BJ, Ren Z, Keebler J, Han Y, Levy SE, Boone BE, Wimbish JR, Waite LL, Jones AL, Carulli JP, Day-Williams AG, Staropoli JF, Xin WW, Chesi A, Raphael AR, McKenna-Yasek D, Cady J, Vianney de Jong JM, Kenna KP, Smith BN, Topp S, Miller J, Gkazi A; FALS Sequencing Consortium, Al-Chalabi A, van den Berg LH, Veldink J, Silani V, Ticozzi N, Shaw CE, Baloh RH, Appel S, Simpson E, Lagier-Tourenne C, Pulst SM, Gibson S, Trojanowski JQ, Elman L, McCluskey L, Grossman M, Shneider NA, Chung WK, Ravits JM, Glass JD, Sims KB, Van Deerlin VM, Maniatis T, Hayes SD, Ordureau A, Swarup S, Landers J, Baas F, Allen AS, Bedlack RS, Harper JW, Gitler AD, Rouleau GA, Brown R, Harms MB, Cooper GM, Harris T, Myers RM, Goldstein DB.

Science. 2015 Mar 27;347(6229):1436-41. doi: 10.1126/science.aaa3650. Epub 2015 Feb 19.

3.

The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder.

Smith BN, Newhouse S, Shatunov A, Vance C, Topp S, Johnson L, Miller J, Lee Y, Troakes C, Scott KM, Jones A, Gray I, Wright J, Hortobágyi T, Al-Sarraj S, Rogelj B, Powell J, Lupton M, Lovestone S, Sapp PC, Weber M, Nestor PJ, Schelhaas HJ, Asbroek AA, Silani V, Gellera C, Taroni F, Ticozzi N, Van den Berg L, Veldink J, Van Damme P, Robberecht W, Shaw PJ, Kirby J, Pall H, Morrison KE, Morris A, de Belleroche J, Vianney de Jong JM, Baas F, Andersen PM, Landers J, Brown RH Jr, Weale ME, Al-Chalabi A, Shaw CE.

Eur J Hum Genet. 2013 Jan;21(1):102-8. doi: 10.1038/ejhg.2012.98. Epub 2012 Jun 13.

4.

Primary lateral sclerosis as a phenotypic manifestation of familial ALS.

Brugman F, Wokke JH, Vianney de Jong JM, Franssen H, Faber CG, Van den Berg LH.

Neurology. 2005 May 24;64(10):1778-9.

PMID:
15911810
5.

Euthanasia and physician-assisted suicide among patients with amyotrophic lateral sclerosis in the Netherlands.

Veldink JH, Wokke JH, van der Wal G, Vianney de Jong JM, van den Berg LH.

N Engl J Med. 2002 May 23;346(21):1638-44.

6.

48th ENMC International Workshop: drug trials and clinical research in ALS. 12-14 January 1997, Naarden, The Netherlands.

Vianney de Jong JM.

Neuromuscul Disord. 1997 Sep;7(6-7):404-6. No abstract available.

PMID:
9327406
7.

Expression of different metallothionein messenger ribonucleic acids in motor cortex, spinal cord and liver from patients with amyotrophic lateral sclerosis.

Blaauwgeers HG, Anwar Chand M, van den Berg FM, Vianney de Jong JM, Troost D.

J Neurol Sci. 1996 Oct;142(1-2):39-44.

PMID:
8902718
8.

Enhanced superoxide dismutase-2 immunoreactivity of astrocytes and occasional neurons in amyotrophic lateral sclerosis.

Blaauwgeers HG, Vianney de Jong JM, Verspaget HW, van den Berg FM, Troost D.

J Neurol Sci. 1996 Sep 1;140(1-2):21-9.

PMID:
8866423
9.

Prognostic values of electroneurographic and electromyographic features in amyotrophic lateral sclerosis.

Louwerse ES, Posthumus Meyjes FE, Sillevis Smitt JH, Redekop WK, Bossuyt PM, Vianney de Jong JM, Ongerboer de Visser BW.

J Neurol Sci. 1995 May;129 Suppl:29. No abstract available.

PMID:
7595613
10.

Percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis and impaired pulmonary function.

Mathus-Vliegen LM, Louwerse LS, Merkus MP, Tytgat GN, Vianney de Jong JM.

Gastrointest Endosc. 1994 Jul-Aug;40(4):463-9.

PMID:
7926537
11.
12.
13.

Effects of midline medullary lesions on velocity storage and the vestibulo-ocular reflex.

Katz E, Vianney de Jong JM, Buettner-Ennever J, Cohen B.

Exp Brain Res. 1991;87(3):505-20.

PMID:
1783021
14.

Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis.

Troost D, Van den Oord JJ, Vianney de Jong JM.

Neuropathol Appl Neurobiol. 1990 Oct;16(5):401-10.

PMID:
2263315
15.

Compensation for labyrinthine defects examined by use of a tilting room.

Bles W, Vianney de Jong JM, de Wit G.

Acta Otolaryngol. 1983 May-Jun;95(5-6):576-9.

PMID:
6880668
16.

Muscle and central nervous system metamorphosis. Histology and autoradiography.

den Jager Hartog WA, de Jong JM, Vianney de Jong JM, Schoot JB, van der.

Arch Neurol. 1973 Mar;28(3):191-4. No abstract available.

PMID:
4539814

Supplemental Content

Loading ...
Support Center